CD274 and cancer: In a study including 120 advanced cancer patients treated with anti-PD-1 or anti-PD-L1 inhibitors for any cancer type, a higher PILE score is associated with decreased PFS and OS, showing PILE as a prognostic score system candidate for immunotherapy (24).